Recursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now?

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs ...
RealClearScience

Compound From Python Blood Could Drive Healthy Weight Loss

CU Boulder researchers have discovered an appetite-suppressing compound in python blood that helps the snakes consume enormous meals and go months without eating yet remain metabolically healthy. The ...
sharewise

If You'd Invested $1,000 in Recursion Pharmaceuticals 4 Years Ago, Here's How Much You'd Have Today

Recursion Pharmaceuticals (NASDAQ: RXRX), a biotech company focused on artificial intelligence (AI), went public in April 2021. This was before ChatGPT, before AI became the hottest topic on Wall ...
The Globe and Mail

Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced ...
Yahoo Finance

This Beaten-Down Artificial Intelligence (AI) Stock Just Got Some Great News: Time to Buy?

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
IEEE

Image Recovery by Recursive Spline Smoothing and Application to Recognition of Compound Structures

Abstract: In this paper we propose approach for special data post-processing, based on Recursive Spline Smoothing method, adapted to image reconstruction. The description of the special MATLAB program ...
C&EN

Machine Learning Methodologies Applied to Magnetocaloric Perovskites Discovery

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Traditionally, designing novel materials involves exploring new compositions guided by ...